BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bani-Hani KE, Bani-Hani BK, Martin IG. Characteristics of patients with columnar-lined Barrett’s esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol 2005; 11(43): 6807-6814 [PMID: 16425388 DOI: 10.3748/wjg.v11.i43.6807]
URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6807.htm
Number Citing Articles
1
A Kahn, M Al-Qaisi, V T Kommineni, J K Callaway, E S Boroff, G E Burdick, D M Lam-Himlin, M Temkit, M F Vela, F C Ramirez. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasiaDiseases of the Esophagus 2018; 31(4) doi: 10.1093/dote/dox120
2
Neel Sharma, Khek Yu Ho. Columnar lined Barrett's oesophagusBritish Journal of Hospital Medicine 2015; 76(12): 703 doi: 10.12968/hmed.2015.76.12.703
3
S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou, X-P Zou. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysisBritish Journal of Cancer 2014; 110(9): 2378 doi: 10.1038/bjc.2014.127
4
Sachin Wani, Gary Falk, Matthew Hall, Srinivas Gaddam, Amy Wang, Neil Gupta, Mandeep Singh, Vikas Singh, Keng–Yu Chuang, Vikram Boolchand, Hemanth Gavini, John Kuczynski, Priti Sud, Savio Reddymasu, Ajay Bansal, Amit Rastogi, Sharad C. Mathur, Patrick Young, Brooks Cash, David A. Lieberman, Richard E. Sampliner, Prateek Sharma. Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal AdenocarcinomaClinical Gastroenterology and Hepatology 2011; 9(3): 220 doi: 10.1016/j.cgh.2010.11.008
5
Zhifeng Lou, Haibo Xing, Da Li, Ken-ichi Mukaisho. Alcohol Consumption and the Neoplastic Progression in Barrett's Esophagus: A Systematic Review and Meta-AnalysisPLoS ONE 2014; 9(10): e105612 doi: 10.1371/journal.pone.0105612
6
Muhammad H. Zeb, Anushka Baruah, Sarah K. Kossak, Navtej S. Buttar. Chemoprevention in Barrett’s EsophagusGastroenterology Clinics of North America 2015; 44(2): 391 doi: 10.1016/j.gtc.2015.02.009
7
David Armstrong. Should patients with Barrett's oesophagus be kept under surveillance? The case forBest Practice & Research Clinical Gastroenterology 2008; 22(4): 721 doi: 10.1016/j.bpg.2008.03.002
8
Licia Pensabene, Marta C. Cohen, Michael Thomson. Clinical Implications of Molecular Changes in Pediatric Barrett’s EsophagusCurrent Gastroenterology Reports 2012; 14(3): 253 doi: 10.1007/s11894-012-0252-x
9
Kamal E Bani‐Hani, Bayan K Bani‐Hani. Columnar lined (Barrett's) esophagus: Future perspectivesJournal of Gastroenterology and Hepatology 2008; 23(2): 178 doi: 10.1111/j.1440-1746.2007.05137.x
10
Dipesh Solanky, Rajesh Krishnamoorthi, Nicholas Crews, Michele Johnson, Kenneth Wang, Herbert Wolfsen, David Fleischer, Francisco C. Ramirez, David Katzka, Navtej Buttar, Prasad G. Iyer. Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal AdenocarcinomaJournal of Clinical Gastroenterology 2019; 53(5): 361 doi: 10.1097/MCG.0000000000001027
11
Ayesha Noorani, Rebecca C. Fitzgerald. Esophageal cancer and barrett's esophagus2015; : 55 doi: 10.1002/9781118655153.ch6
12
Ganapathy A Prasad, Ajay Bansal, Prateek Sharma, Kenneth K Wang. Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future DirectionsAmerican Journal of Gastroenterology 2010; 105(7): 1490 doi: 10.1038/ajg.2010.2
13
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine, P M Price, I M Welch, C M L West. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequenceBritish Journal of Cancer 2007; 96(9): 1377 doi: 10.1038/sj.bjc.6603744
14
Pieter Jan F de Jonge, Mark van Blankenstein, William M Grady, Ernst J Kuipers. Barrett's oesophagus: epidemiology, cancer risk and implications for managementGut 2014; 63(1): 191 doi: 10.1136/gutjnl-2013-305490
15
David C Whiteman, Bradley J Kendall. Barrett's oesophagus: epidemiology, diagnosis and clinical managementMedical Journal of Australia 2016; 205(7): 317 doi: 10.5694/mja16.00796
16
Kamal E Bani‐Hani, Bayan K Bani‐Hani. Columnar‐lined esophagus: Time to drop the eponym of “Barrett”: Historical reviewJournal of Gastroenterology and Hepatology 2008; 23(5): 707 doi: 10.1111/j.1440-1746.2008.05386.x
17
Fouad Yousef, Chris Cardwell, Marie M. Cantwell, Karen Galway, Brian T. Johnston, Liam Murray. The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology 2008; 168(3): 237 doi: 10.1093/aje/kwn121
18
Kavel Visrodia, Siddharth Singh, Rajesh Krishnamoorthi, David A. Ahlquist, Kenneth K. Wang, Prasad G. Iyer, David A. Katzka. Magnitude of Missed Esophageal Adenocarcinoma After Barrett’s Esophagus Diagnosis: A Systematic Review and Meta-analysisGastroenterology 2016; 150(3): 599 doi: 10.1053/j.gastro.2015.11.040
19
Yong Kang Lee. Barrett's EsophagusThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2022; 22(3): 177 doi: 10.7704/kjhugr.2022.0015
20
Anushka Baruah, Navtej S. Buttar. Chemoprevention in Barrett's oesophagusBest Practice & Research Clinical Gastroenterology 2015; 29(1): 151 doi: 10.1016/j.bpg.2014.12.003
21
Ai Kubo, T. R. Levin, Gladys Block, Gregory Rumore, Charles P. Quesenberry, Patricia Buffler, Douglas A. Corley. Cigarette smoking and the risk of Barrett’s esophagusCancer Causes & Control 2009; 20(3): 303 doi: 10.1007/s10552-008-9244-4
22
J. Akiyama, A. Roorda, G. Triadafilopoulos. Managing Barrett's esophagus with radiofrequency ablationGastroenterology Report 2013; 1(2): 95 doi: 10.1093/gastro/got009
23
Farhad Navab, Brian H. Nathanson, David J. Desilets. The impact of lifestyle on Barrett’s Esophagus: A precursor to esophageal adenocarcinomaCancer Epidemiology 2015; 39(6): 885 doi: 10.1016/j.canep.2015.10.013
24
Sharmila Anandasabapathy, Jagriti Jhamb, Marta Davila, Caimiao Wei, Jeffrey Morris, Robert Bresalier. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasiaCancer 2007; 109(4): 668 doi: 10.1002/cncr.22451
25
Esther Klaver, Angela Bureo Gonzalez, Nahid Mostafavi, Rosalie Mallant‐Hent, Lucas C. Duits, Bert Baak, Clarisse J. M. Böhmer, Arnoud H. A. M. van Oijen, Ton Naber, Pieter Scholten, Sybren L. Meijer, Jacques J. G. H. M. Bergman, Roos E. Pouw. Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progressionUnited European Gastroenterology Journal 2021; 9(8): 929 doi: 10.1002/ueg2.12114